SURGE Therapeutics
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 3 Trial of SRG-514 Administered Intraoperatively to Patients Undergoing Breast-Conserving Surgery (NCT07723469) | SURGE Therapeutics | 2026-10-01 |
| Study of STM-416p Administered to Patients Undergoing Radical Prostatectomy (NCT06450106) | SURGE Therapeutics | 2025-05-08 |
| SRG-514 Administered Intraoperatively to Patients Undergoing Breast-conserving Cancer Surgery (NCT06300411) | SURGE Therapeutics | 2024-07-29 |
| A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer (NCT05710848) | SURGE Therapeutics | 2023-07-11 |
Track SURGE Therapeutics automatically
Every clearance here is in the API, with alerts when new ones post.